"We had a very good quarter. We successfully strengthened our underlying business momentum through good new business gains, effective deployment of new program launches which enabled us to further help our customers meet their operating and sustainability goals, and continued delivery of committed synergies," said Douglas M. Baker, Jr., Ecolab's chairman and chief executive officer. "In addition, our newly-acquired Champion business performed above our expectations which added to an already strong performance."
Second quarter 2013 sales for the Global Institutional segment, when measured at fixed currency rates, rose 3% to more than $1 billion, led by strong Global Specialty sales growth. The Global Institutional business reported moderate sales growth while Global Healthcare sales declined slightly. Sales for the segment showed strong growth in Latin America with good gains in Asia Pacific and North America, which more than offset lower sales in EMEA
For the six months, Ecolab's sales rose 8% to $5.7 billion. Net income increased 59% to $372 million. Global institutional sales increased 3% to $2 billion.